The FDA approved a new medication Olumiant for alopecia based on two double-blind, placebo-controlled clinical trials. Dr Suzanne Friedler, FAAD, a dermatologist sees this medication as best for younger and healthier patients.
The FDA approved a new medication Olumiant for alopecia based on two double-blind, placebo-controlled clinical trials. Dr Suzanne Friedler, FAAD, a dermatologist sees this medication as best for younger and healthier patients.
With 50+ locations conveniently located throughout New York City and New Jersey, a top-rated dermatologist is just around the corner. Click below to find the office nearest you!
Receive skincare tips, news and special offers!
This will close in 0 seconds